You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Medicines Called Enzalutamide and Abiraterone in People With

Not yet recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • New York, New York
    Pfizer Inc
Jul 21, 2023

Metastatic Castration-resistant Prostate Cancer Trial (Darolutamide, Docetaxel or cabazitaxel)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • (no location specified)
Feb 28, 2023

Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer Trial in

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • Vancouver, British Columbia, Canada
    BC Cancer
Nov 28, 2022

Metastatic Castration Resistant Prostate Cancer, Prostate Tumors Trial run by the NCI (enzalutamide, CRLX101)

Terminated
Has Results
  • Metastatic Castration Resistant Prostate Cancer
  • Prostate Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 16, 2022

Metastatic Castration-resistant Prostate Cancer Trial (HP518 - Dose Escalation, HP518 -Dose Expansion)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • HP518 - Dose Escalation
  • HP518 -Dose Expansion
  • (no location specified)
Dec 1, 2023

Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Seoul ([177Lu]Ludotadipep)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer, mCRPC
  • Seoul, Korea, Republic of
    The Catholic University of Korea, Seoul, St, Mary's Hospital, 22
Dec 8, 2022

Metastatic Castration Resistant Prostate Cancer Trial in China (AC176)

Not yet recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Beijing, China
  • +4 more
Jan 4, 2023

Prostate Cancer Metastatic Trial (MK-5684, Abiraterone acetate, Enzalutamide)

Not yet recruiting
  • Prostate Cancer Metastatic
  • (no location specified)
Nov 21, 2023

Prostate Cancer Trial in Boston, Brooklyn, New York (225Ac-J591, Pembrolizumab, Androgen receptor pathway inhibitor)

Recruiting
  • Prostate Cancer
  • Boston, Massachusetts
  • +3 more
Sep 20, 2021

Castration Resistant Prostate Cancer, CRPC Trial in Seoul (Cellgram-DC-PC)

Terminated
  • Castration Resistant Prostate Cancer, CRPC
  • Cellgram-DC-PC
  • Seoul, Korea, Republic of
    Asan medical center
Dec 29, 2022

Prostate Cancer Trial in San Francisco (CTT1403, CTT1057, 68Ga-PSMA-11)

Active, not recruiting
  • Prostate Cancer
  • San Francisco, California
    University of California, San Francisco
Apr 14, 2022

Metastatic Castration-resistant Prostate Cancer Trial (Pembrolizumab, Enzalutamide)

Completed
  • Metastatic Castration-resistant Prostate Cancer
  • (no location specified)
Aug 16, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Guangzhou (Pamiparib)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Apr 7, 2022

Metastatic Castration-resistant Prostate Cancer, mCRPC, Prostate Cancer Trial in Melbourne (Lutetium-177 PSMA-I&T, Radium-223)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Sep 26, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Bortezomib)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Sep 7, 2023

Metastatic Castration-Resistant Prostate Cancer Patients Trial in Copenhagen (Irofulven, Prednisolone 10 mg)

Active, not recruiting
  • Metastatic Castration-Resistant Prostate Cancer Patients
  • Copenhagen, Denmark
    Rigshospitalet, Dept. Of Oncology
Feb 1, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Finland, Netherlands, United Kingdom (BAY3546828, BAY2616505,

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Helsinki, Finland
  • +3 more
Sep 18, 2023

Metastatic Castration-resistant Prostate Cancer Trial (TmPSMA-02)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • TmPSMA-02
  • (no location specified)
Aug 3, 2022

Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Trial (TmPSMA-02 CAR T Cells)

Not yet recruiting
  • Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
  • TmPSMA-02 CAR T Cells
  • (no location specified)
Sep 13, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +6 more
  • San Francisco, California
    University of California, San Francisco
Sep 8, 2022

Castration Resistant Prostatic Cancer, Metastatic Prostate Cancer Trial in San Francisco (Pembrolizumab, Chemotherapy)

Active, not recruiting
  • Castration Resistant Prostatic Cancer
  • Metastatic Prostate Cancer
  • San Francisco, California
    University of California, San Francisco
May 17, 2022

Prostate Cancer Trial in Brazil (Testosterone Cypionate, Darolutamide)

Recruiting
  • Prostate Cancer
  • Brasília, Distrito Federal, Brazil
  • +4 more
Dec 22, 2022

Metastatic Prostate Cancer in Pirkanmaa Hospital District in

Not yet recruiting
  • Metastatic Castration Sensitive Prostate Cancer (mCSPC)
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 17, 2023

Prostate Cancer, Castration-resistant Prostate Cancer Trial in São Paulo (Docetaxel, Enzalutamide)

Active, not recruiting
  • Prostate Cancer
  • Castration-resistant Prostate Cancer
  • São Paulo, SP, Brazil
    Instituto do Câncer do Estado de São Paulo
Sep 14, 2022

Prostate Cancer Trial in Boston (Radium-223, Pembrolizumab)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Aug 31, 2022